Abstract
Objective
To describe the shared care and outcomes of patients with periocular skin tumours who underwent Mohs micrographic surgery (MMS) performed by dermatologists, followed by oculoplastic reconstruction undertaken by ophthalmologists at two teaching and one private hospital in Ireland.
Research design and methods
This was a retrospective chart review at the Royal Victoria Eye and Ear Hospital, St James Hospital and the Hermitage Clinic.
Results
One hundred and twenty seven patients had periocular Mohs surgery between November 2006 and January 2013 mainly indicated for basal cell carcinoma. The mean follow-up time was 2 years and to date there have been no local recurrences.
Conclusions
MMS is available in Ireland and should be considered for patients with facial tumours in the ocular region.
Similar content being viewed by others
References
Mohs F (1941) Chemosurgery: a microscopically controlled method of cancer excision. Arch Surg 42:279–295
Shriner DL, Mc Coy DK, Goldberg DJ, Wagner RF (1998) Mohs micrographic surgery. J Am Acad Dermatol 39:79–97
Fe Mohs (1986) Micrographic surgery for the microscopically controlled excision of eyelid cancers. Arch Ophthalmol 104:901–909
Vuyk HD, Lohuis PJ (2001) Mohs micrographic surgery for facial skin cancer. Clin Otolaryngol Allied Sci 26:265–273
Panje WR, Cheilley RI (1979) The influence of embryology of the midface on spread of epithelial malignancies. Laryngoscope 89:1914–1920
Robins P, Albom MJ (1975) Recurrent basal cell carcinoma in young women. J Dermatol Surg 1:49–51
Marsden JR, Newton-Bishop JA, Burrows L et al (2010) Revised UK guidelines for the management of cutaneous melanoma 2010. Br J Dermatol 163:238–256
Kuijpers DIM, Thissen M, Neumann HAM (2002) Basal cell carcinoma treatment options and prognosis, a scientific approach to common malignancy. Am J Clin Dermatol 3:247–259
Bath-Hextall FJ, Perkins W, Bong J, Williams HC (2007) Interventions for basal cell carcinoma of the skin. Cochrane Database Syst Rev 1: CD003412
Mosterd K, Krekels GA, Nieman FH et al (2008) Surgical excision versus Mohs micrographic surgery for primary and recurrent basal cell carcinoma of the face: a prospective randomized controlled trial with 5 years follow up. Lancet Oncol 9:1149–1156
Krekels GA, Ostertag JU, Essers BA, Dirksen CD, Nieman FH, Neumann HA (2004) Surgical excision vs. Mohs’ micrographic surgery for basal cell carcinoma of the face: randomized controlled trial. Lancet 364(9447):1766–1772
Narayanan K, Hadid OH, Barnes EA (2012) Cochrane Database Syst Rev 2:CD007041
Staples MP, Elwood M, Burton RC, Williams JL, Marks R, Giles GG (2006) Non melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust 184:6–10
Leibovitch I, Huigol SC, Selva D, Richards S, Payer R (2005) Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5 year follow-up. J Am Acad Dermatol 53(3):452–457
Malhotra R, Huilgol SC, Huynh NT, Selva D (2004) The Australian Mohs database, part 1. Periocular basal cell carcinoma experience over 7 years. Ophthalmology 111:624–630
Silverman MK, Kopf AW, Grin CM et al (1992) Recurrence rates of treated basal cell carcinomas part 3: surgical excision. J Dermatol Surg Oncol 18:471–476
Hamada S, Kersey T, Thaller VT (2005) Eyelid basal call carcinoma: non-Mohs excision, repair and outcome. Br J Ophthalmol 89:992–994
Thissen MR, Neumann MH, Schouten LJ (1999) A systematic review of treatment modalities for primary basal cell carcinomas. Arch Dermatol 135:1177–1183
Rowe DE, Carroll RJ, Day CL (1989) Long-term recurrence rates for recurrent (previously treated) basal cell carcinomas. J Dermatol Surg and Oncol 15:424–431
Paoli J, Daryoni S, Wennberg AM et al (2011) 5 Year recurrence rates of Mohs micrographic surgery for aggressive and recurrent basal cell carcinoma. Acta Derm Venereol 91:689–693
Lindgren G, Lindbom B, Larko O (2000) Mohs micrographic surgery for basal cell carcinomas on the eyelids and medial canthal area II. Reconstruction and follow-up. Acta Ophthalmol Scandinavia 78:430–436
Rippey JJ (1998) Why classify basal cell carcinomas? Histopathology 32:393–398
Emmett AJJ (1990) Surgical analysis and biological behaviour of 2277 basal cell carcinomas. Aust NZ J Surg 60:855–863
Wade TR, Ackerman AB (1978) The many faces of basal cell carcinoma. J Dermatol Surg Oncol 4:23–28
Silverman MK, Kopf AW, Grin CM et al (1991) Recurrence rates of treated basal cell carcinomas. Part 1: overview. J Dermatol Surg Oncol 17:713–718
Rowe DE, Carroll RJ, Day CL (1989) Long-term recurrence rates in previously untreated (primary) basal cell carcinomas: implications for patient follow-up. J Dermatol Surg Oncol 15:315–328
Smeets NWJ, Kuijpers DIM, Nelemans P et al (2004) Mohs micrographic surgery for treatment of basal cell carcinoma of the face—results of a retrospective study and review of the literature. Br J Dermatol 151:141–147
Robins P, Rodriguez-Sains R, Rabinovitz H, Rigel D (1985) Mohs surgery for periocular basal cell carcinomas. J Dermatol Surg Oncol 12:1203–1207
Malhotra R, Huigol SVC, Huynh NT, Selva D (2004) The Australian Mohs database: periocular squamous cell carcinoma. Ophthalmology 111(4):617–623
Bernstein SC, Lim KK, Brotland DG et al (1996) The many faces of squamous cell carcinoma. J Dermatol Surg 22:243–254
Slutsky JB, Jones EC (2012) Periocular cutaneous malignancies: a review of the literature. Dermatol Surg 38:552–569
Brodland DG, Zitelli JA (1992) Surgical margins for excision of primary cutaneous squamous cell carcinoma. J Am Acad Dermatol 27:241–248
Rowe DE, Carroll RJ, Day CL (1992) Prognostic factors for local recurrance, metastasis and survival rates in squamous cell carcinoma of the skin ear and lip. J Am Acad Dermatol 9:724–728
Dzubow LM, Rigel DS, Robins P (1982) Risk factors for local recurrence of primary cutaneous SCC. Treatment by microscopically controlled excision. Arch Dermatol 118:900–902
Kass LG, Hornblass A (1989) Sebaceous carcinoma of the ocular adnexa. Surg Ophthalmol 33:477–490
Lai TF, Huigol SC, Selva D, James CL (2004) Eyelid sebaceous carcinoma masquerading as in situ squamous cell carcinoma. Dermatol Surg 30:222–225
Eisen DB, Michael DJ (2009) Sebaceous lesions and their associated syndromes. J Am Acad Dermatol 61(4):549–578
Snow SN, Larson PO, Lucarelli MJ, Lemke BN, Madjar DD (2002) Sebaceous carcinoma of the eyelids treated by Mohs micrographic surgery: report of nine cases with review of the literature. Dermatol Surg 28:623–631
Gaston DA, Naugle C, Clark DP (1999) Mohs micrographic surgery referral patterns: the University of Missouri experience. Dermatol Surg 25:862–866
Neumann HAM, Krekels GAM, Verheagh MEJM (1996) Treatment of 208 extensive basal cell carcinomas with Mohs micrographic surgery. J Eur Acad Dermatol Venerol 6:217–225
Essers BA, Dirksen CD, Nieman FH et al (2006) Cost-effectiveness of Mohs micrographic surgery vs. surgical excision for basal cell carcinoma of the face. Arch Dermatol 142:187–194
Bialy TL, Whalen J, Veledar E et al (2004) Mohs micrographic surgery vs. traditional excision a cost comparison analysis. Arch Dermatol 140:736–742
Cook J, Zitelli JA (1998) Mohs micrographic surgery: a cost analysis. J Am Acad Dermatol 39:698–703
Kwon S, Godsey T, Gloster HM (2013) Evaluation of residual tumour from Mohs micrographic specimens of clinically resolved preoperative biopsy sites. Dermatol Surg 39:487–489
Hussain W, Hafiji J, Salmon P (2012) The utility of the book biopsy in Mohs micrographic surgery. Br Assoc Dermatol 167:701–702
Presser SE, Taylor JR (1987) Clinical diagnostic accuracy of basal cell carcinoma. J Am Acad Dermatol 16:988–990
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Treacy, M.P., Wynne, N.C., Gale, J.L. et al. Mohs micrographic surgery for periocular skin tumours in Ireland. Ir J Med Sci 185, 779–783 (2016). https://doi.org/10.1007/s11845-015-1296-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-015-1296-3